Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Lisa L. Ioannides-Demos"'
Publikováno v:
Journal of Obesity, Vol 2011 (2011)
Past therapies for the treatment of obesity have typically involved pharmacological agents usually in combination with a calorie-controlled diet. This paper reviews the efficacy and safety of pharmacotherapies for obesity focusing on drugs approved f
Externí odkaz:
https://doaj.org/article/3d1b5e666b4b46a1bdcd59fc8cdb2ffd
Autor:
Lisa L Ioannides-Demos, John J McNeil
Publikováno v:
Internal Medicine Review. 3
Publikováno v:
Pharmaceutical Medicine. 24:281-288
In the past, postmarketing surveillance of drugs relied mainly on the spontaneous reporting of adverse drug reactions. There are now several other approaches used, including databases with individual prescription data (or prescription event monitorin
Publikováno v:
Cardiovascular Drugs and Therapy. 24:359-367
Smoking continues to be a major contributor to the burden of disease across the world although there has been a decrease in some developed countries such as USA and Australia. In countries of South-East Asia with a high prevalence of smoking, the inc
Publikováno v:
Monash University
Background The management of chronic obstructive pulmonary disease (COPD) requires a disease management approach—a combination of pharmacotherapy, pulmonary rehabilitation and behavioural changes. Patient adherence to therapy has been found to be p
Publikováno v:
Drug Safety. 29:277-302
Some of the medications used for weight loss in the management of obesity have been associated with unacceptable morbidity and mortality. Safety concerns have led to the withdrawal of aminorex, followed by the fenfluramines in 1997, and phenylpropano
Autor:
Julie A V Lord, Graham Byrnes, Jonathan Dartnell, Lisa L Ioannides-Demos, Liliana Munafo, Tony M. Korman, Marion B Robertson, Sue W Kirsa
Publikováno v:
Monash University
Objective To determine patterns of use of ceftriaxone and cefotaxime (CEFX) in Victorian hospitals and to identify areas for improvement. Design, patients and setting A concurrent, observational evaluation of CEFX use in patients commencing a course
Publikováno v:
PharmacoEconomics. 20:577-591
Pharmaceutical expenditure is rising more rapidly than the general inflation rate in most advanced countries. One strategy that has been introduced to control pharmaceutical costs is reference-based pricing (RBP). Its potential is restricted to those
Autor:
R. Addicott, M. McKenzie, Lisa L Ioannides-Demos, Nick Santamaria, Christopher K Fairley, L. Clayton
Publikováno v:
Internal Medicine Journal. 31:142-145
Aim: To determine whether the apparently longer length of stay (LOS) reported for patients with cellulitis managed in Hospital in the Home (HITH) compared with those managed as inpatients was correct. Methods: Data, including LOS, from the Victorian
Autor:
Lisa L Ioannides-Demos
Publikováno v:
The Australian Journal of Hospital Pharmacy. 29:16-19
Objective: To determine the extent of pharmacy services and drug usage for Hospital-in-the-Home (HITH) programs in Victoria. Method: In 1997, 42 Victorian hospital pharmacies with HITH services were surveyed by a questionnaire on services and drug us